AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study
Abstract Background Most hepatocellular carcinoma (HCC) patients’ liver function indexes are abnormal. We aimed to investigate the relationship between (alkaline phosphatase + gamma-glutamyl transpeptidase)/lymphocyte ratio (AGLR) and the progression as well as the prognosis of HCC. Methods A total...
Main Authors: | Yan Liao, Rongyu Wei, Renzhi Yao, Liling Qin, Jun Li, Junxiong Yu, Weijia Liao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | BMC Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12893-020-01037-7 |
Similar Items
-
Prognostic Value of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in Patients With Single Tumor Size ≤ 5 cm Hepatocellular Carcinoma After Radical Resection
by: Minjun Liao, et al.
Published: (2019-05-01) -
A Novel Post-Operative ALRI Model Accurately Predicts Clinical Outcomes of Resected Hepatocellular Carcinoma Patients
by: Minjun Liao, et al.
Published: (2021-07-01) -
Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
by: Xiaoyi Hu, et al.
Published: (2020-09-01) -
High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma
by: Zheng W, et al.
Published: (2018-11-01) -
Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
by: Xiaoyi Hu, et al.
Published: (2020-11-01)